Pubblicazioni

In Vivo and Ex Vivo Patient-Derived Tumor Xenograft Models of Lymphoma for Drug Discovery

2021 - CURRENT PROTOCOLS

Cacciapuoti, M. T.; Cappelli, L. V.; Fiore, D.; Toruno, P.; Kayembe, C.; Tam, W.; Inghirami, G.

Inhibition of STAT3 with the generation 2.5 antisense oligonucleotide, AZD9150, decreases neuroblastoma tumorigenicity and increases chemosensitivity

2017 - CLINICAL CANCER RESEARCH

Odate, S.; Veschi, V.; Yan, S.; Lam, N.; Woessner, R.; Thiele, C. J.

ErbB-3 activation by NRG-1Î² sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs)

2015 - ONCOTARGET

Prasetyanti, Pramudita R.; Capone, Emily; Barcaroli, Daniela; D'Agostino, Daniela; Volpe, Silvia; Benfante, Antonina; van Hooff, Sander; Iacobelli, Valentina; Rossi, Cosmo; Iacobelli, Stefano; Medema, Jan Paul; de Laurenzi, Vincenzo; Sala, Gianluca